21:55:53 EDT Tue 19 May 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:LOBEF - LOBE SCIENCES LTD - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
LOBEF - Qnot subscribed0.104+0.004925.067.56210.105  0.10855  0.091170.1082  0.017314:12:54May 0615 min RT 2¢

Recent Trades - Last 10 of 21
Time ETExPriceChangeVolume
14:12:54Q0.1040.004921,208
12:49:42Q0.107550.00847500
12:49:15Q0.09678-0.0023500
12:48:50Q0.09117-0.00791500
12:48:22Q0.09117-0.00791500
12:47:57Q0.09117-0.00791500
12:47:30Q0.09117-0.00791500
12:47:08Q0.09865-0.00043500
11:49:59Q0.1080.008922,000
11:25:22Q0.108550.009473,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-06 20:00U:LOBEFNews ReleaseLobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
2026-05-06 06:00U:LOBEFNews ReleaseLobe Sciences Reports Second Quarter 2026 Results and Highlights Continued Operational Progress
2026-04-23 08:00U:LOBEFNews ReleaseLobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
2026-04-21 06:00U:LOBEFNews ReleaseLobe Sciences Ltd. Engages Massive Intelligence Pty Ltd for Investor Relations and Corporate Communications Services
2026-04-20 06:00U:LOBEFNews ReleaseLobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement and Provides Corporate Update
2026-04-10 20:00U:LOBEFNews ReleaseLobe Sciences Ltd. Announces Non-Brokered Private Placement
2026-03-25 08:20U:LOBEFNews ReleaseLobe Sciences Ltd. Reports Improved Financial Position and Strategic Update
2026-03-09 00:00U:LOBEFNews ReleaseLobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer
2026-03-05 07:41U:LOBEFNews ReleaseLobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
2026-02-03 07:00U:LOBEFNews ReleaseLobe Sciences Reports First Quarter 2026 Results and Highlights
2026-01-13 07:00U:LOBEFNews ReleaseLobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
2026-01-08 08:57U:LOBEFNews ReleaseLobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
2026-01-06 06:00U:LOBEFNews ReleaseLobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
2025-10-23 23:50U:LOBEFNews ReleaseLobe Sciences Completes Debt Settlement to Improve Balance Sheet
2025-10-09 06:50U:LOBEFNews ReleaseLobe Sciences Improves Balance Sheet
2025-09-15 23:51U:LOBEFNews ReleaseLobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto
2025-09-09 23:50U:LOBEFNews ReleaseLobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
2025-09-09 00:01U:LOBEFNews ReleaseLobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors
2025-08-14 23:00U:LOBEFNews ReleaseLobe Sciences Announces the Closing of the Previously Announced Private Placement
2025-07-29 00:10U:LOBEFNews ReleaseLobe Sciences Announces $341,425 CAD Private Placement for General Corporate Purposes